Susquehanna International Group’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Susquehanna International Group’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-30,172	Closed	-$302K	–	14570
2022 Q3	$302K	Sell	30,172 -114,847	-79%	-$1.14M	﹤0.01%	9780
2022 Q2	$1.43M	Buy	145,019 +7,831	+6%	+$77.3K	﹤0.01%	5660
2022 Q1	$1.35M	Buy	137,188 +31,050	+29%	+$305K	﹤0.01%	6387
2021 Q4	$1.04M	Buy	106,138 +74,929	+240%	+$738K	﹤0.01%	7193
2021 Q3	$306K	Buy	31,209 +8,842	+40%	+$87.1K	﹤0.01%	10563
2021 Q2	$221K	Sell	22,367 -7,384	-25%	-$74.3K	﹤0.01%	11393
2021 Q1	$306K	Buy	+29,751	New	+$330K	﹤0.01%	10563

Susquehanna International Group's LUXA Position: Q4 2022 in Review

Susquehanna International Group sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 30,172 shares — an estimated $302K sold.

Susquehanna International Group first reported a position in LUXA in Q1 2021 and held it in 7 quarters. The position peaked at $1.43M in Q2 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

Susquehanna International Group reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Susquehanna International Group sold 30,172 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $302K.
Susquehanna International Group first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
Susquehanna International Group's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $1.43M in Q2 2022.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.